CoChat
Sign Up
Cited by 8

Brief exposure to Swedish snus causes divergent vascular responses in healthy male and female volunteers

Antoniewicz, Lukasz, Novo, Mirza, Bosson, Jenny, Lundbäck, Magnus·2018·PLOS ONE
DOI 10.1371/journal.pone.0195493PMC PMC5905986
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0195493

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Acute snus exposure in snus users compared to non-users increases systolic blood pressure, diastolic blood pressure, and heart rate 30 minutes post exposure.

    “observed an increase in systolic blood pressure (SBP) (115 ± 9 vs. 109.2± 6.8 mmHg; p < 0.001 for females; 124.5 ± 10 vs. 120.5 ± 9 mmHg; p < 0.05 for males), diastolic blood pressure (DBP) (72.1 ± 6.9 vs. 67.3± 6.3 mmHg; p < 0.001 for females) and heart rate (HRT) (66.7 ± 11.2 vs. 57.8± 9.8 bpm; p < 0.001 for females) in snus users compared to non-users 30 min post exposure.”

    From Comparison of the Health Effects Associated with the Use of Snus and Tobacco-Free Oral Nicotine Pouches: A Systematic Review (2026) · cites this paper as Antoniewicz et al. 2018

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. [1]Jacobs DR Jr., Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, et al Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Archives of internal medicine. 1999; 159(7): 733– 40. Epub 1999/04/28.. 10218754
  2. [3]Peeters S, Gilmore AB. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials. PLoS medicine. 2013; 10(9): e1001506 Epub 2013/09/24. doi: 10.1371/journal.pmed.1001506; PubMed Central PMCID: PMCPMC3769209. 24058299 PMC3769209 · DOI
  3. [4]Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM. Examining market trends in the United States smokeless tobacco use: 2005–2011. Tob Control. 2012 Epub 2012/11/03. doi: 10.1136/tobaccocontrol-2012-050739; PubMed Central PMCID: PMC3604094. 23117999 PMC3604094 · DOI
  4. [5]Andersson G, Bjornberg G, Curvall M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 1994; 23(4): 161– 7. Epub 1994/04/01.. 8046653
  5. [7]Ostenson CG, Hilding A, Grill V, Efendic S. High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men. Scand J Public Health. 2012; 40(8): 730– 7. Epub 2012/11/03. doi: 10.1177/1403494812459814. 23117209 · DOI · Paper page
  6. [8]Arefalk G, Hergens MP, Ingelsson E, Arnlov J, Michaelsson K, Lind L, et al Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur J Prev Cardiol. 2012; 19(5): 1120– 7. Epub 2011/08/11. doi: 10.1177/1741826711420003. 21828223 · DOI · Paper page
  7. [9]Arefalk G, Hambraeus K, Lind L, Michaelsson K, Lindahl B, Sundstrom J. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation. 2014; 130(4): 325– 32. doi: 10.1161/CIRCULATIONAHA.113.007252. 24958793 · DOI
  8. [10]Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, et al Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012; 27(10): 771– 9. Epub 2012/06/23. doi: 10.1007/s10654-012-9704-8. 22722951 · DOI · Paper page
  9. [11]Hansson J, Pedersen NL, Galanti MR, Andersson T, Ahlbom A, Hallqvist J, et al Use of snus and risk for cardiovascular disease: results from the Swedish Twin Registry. J Intern Med. 2009; 265(6): 717– 24. Epub 2009/06/09.. 19504754
  10. [12]Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil. 2005; 12(4): 387– 92. Epub 2005/08/05. doi: 00149831-200508000-00013 [pii].. 16079648
  11. [13]Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, et al Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med. 2014; 276(1): 87– 95. Epub 2014/02/20. doi: 10.1111/joim.12219. 24548296 · DOI · Paper page
  12. [15]Joksic G, Spasojevic-Tisma V, Antic R, Nilsson R, Rutqvist LE. Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation. Harm Reduct J. 2011; 8(1): 25 Epub 2011/09/15. doi: 10.1186/1477-7517-8-25; PubMed Central PMCID: PMCPMC3186733. 21914165 PMC3186733 · DOI · Paper page
  13. [16]Rutqvist LE. Population-based survey of cessation aids used by Swedish smokers. Harm Reduct J. 2012; 9: 38 Epub 2012/12/05. doi: 10.1186/1477-7517-9-38; PubMed Central PMCID: PMCPMC3539856. 23206988 PMC3539856 · DOI
  14. [17]Lee PN. The effect on health of switching from cigarettes to snus—a review. Regul Toxicol Pharmacol. 2013; 66(1): 1– 5. Epub 2013/03/05. doi: 10.1016/j.yrtph.2013.02.010. 23454227 · DOI
  15. [18]Lee PN. Epidemiological evidence relating snus to health—an updated review based on recent publications. Harm Reduct J. 2013; 10: 36 Epub 2013/12/10. doi: 10.1186/1477-7517-10-36; PubMed Central PMCID: PMCPMC4029226. 24314326 PMC4029226 · DOI
  16. [19]Lee PN. Health risks related to dual use of cigarettes and snus—a systematic review. Regul Toxicol Pharmacol. 2014; 69(1): 125– 34. Epub 2013/11/05. doi: 10.1016/j.yrtph.2013.10.007. 24184647 · DOI
  17. [20]Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health. 2013; 103(5): 923– 30. Epub 2013/03/16. doi: 10.2105/AJPH.2012.301070; PubMed Central PMCID: PMCPMC3661190. 23488521 PMC3661190 · DOI
  18. [21]Gilljam H, Galanti MR. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction. 2003; 98(9): 1183– 9. Epub 2003/08/22.. 12930201
  19. [22]Bolinder G, de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens. 1998; 11(10): 1153– 63. Epub 1998/11/03. doi: S0895-7061(98)00137-X [pii].. 9799031
  20. [23]Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994; 84(3): 399– 404. Epub 1994/03/01. PubMed Central PMCID: PMCPmc1614817. 8129055 PMC1614817
  21. [24]Rohani M, Agewall S. Oral snuff impairs endothelial function in healthy snuff users. J Intern Med. 2004; 255(3): 379– 83. Epub 2004/02/12. doi: 1279 [pii].. 14871462
  22. [25]Hering D, Somers VK, Kara T, Jazdzewski K, Jurak P, Kucharska W, et al Heightened acute circulatory responses to smoking in women. Blood Press. 2008; 17(3): 141– 6. Epub 2008/07/09. doi: 10.1080/08037050802185780. 18608198 · DOI
  23. [27]Adamopoulos D, van de Borne P, Argacha JF. New insights into the sympathetic, endothelial and coronary effects of nicotine. Clinical and experimental pharmacology & physiology. 2008; 35(4): 458– 63. doi: 10.1111/j.1440-1681.2008.04896.x. 18307741 · DOI
  24. [28]Leone A. Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage. Current pharmaceutical design. 2015; 21(30): 4370– 9. Epub 2015/08/04.. 26234797
  25. [29]Christou DD, Jones PP, Jordan J, Diedrich A, Robertson D, Seals DR. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation. 2005; 111(4): 494– 8. Epub 2005/02/03. doi: 10.1161/01.CIR.0000153864.24034.A6. 15687139 · DOI
  26. [31]Zhu SH, Gamst A, Lee M, Cummins S, Yin L, Zoref L. The use and perception of electronic cigarettes and snus among the U.S. population. PloS one. 2013; 8(10): e79332 Epub 2013/11/20. doi: 10.1371/journal.pone.0079332; PubMed Central PMCID: PMCPMC3824062. 24250756 PMC3824062 · DOI
  27. [32]Stegmayr B, Eliasson M, Rodu B. The decline of smoking in northern Sweden. Scand J Public Health. 2005; 33(4): 321– 4; discussion 243. Epub 2005/08/10. doi: 10.1080/14034940510032301. 16087495 · DOI
  28. [33]Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation. 1996; 93(3): 450– 6. Epub 1996/02/01.. 8565161
  29. [34]Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K. Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35–49 years. Journal of clinical epidemiology. 1993; 46(5): 475– 87.. 8501474
  30. [35]Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003; 41(1): 183– 7. Epub 2003/01/04.. 12511550
  31. [36]Kubozono T, Miyata M, Ueyama K, Hamasaki S, Kusano K, Kubozono O, et al Acute and chronic effects of smoking on arterial stiffness. Circulation journal: official journal of the Japanese Circulation Society. 2011; 75(3): 698– 702. Epub 2010/12/29.. 21187657
  32. [37]Benowitz NL, Jacob P 3rd, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. The Journal of pharmacology and experimental therapeutics. 1982; 221(2): 368– 72. Epub 1982/05/01.. 7077531
  33. [38]Adamopoulos D, Argacha JF, Gujic M, Preumont N, Degaute JP, van de Borne P. Acute effects of nicotine on arterial stiffness and wave reflection in healthy young non-smokers. Clinical and experimental pharmacology & physiology. 2009; 36(8): 784– 9. Epub 2009/02/12. doi: 10.1111/j.1440-1681.2009.05141.x. 19207722 · DOI
  34. [39]Du XJ, Cox HS, Dart AM, Esler MD. Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovascular research. 1999; 43(4): 919– 29. doi: 10.1016/s0008-6363(99)00139-x. 10615419 · DOI
  35. [40]Tisdale JE, Patel RV, Webb CR, Borzak S, Zarowitz BJ. Proarrhythmic effects of intravenous vasopressors. The Annals of pharmacotherapy. 1995; 29(3): 269– 81. Epub 1995/03/01. doi: 10.1177/106002809502900309. 7606074 · DOI
  36. [41]Ikarugi H, Taka T, Nakajima S, Noguchi T, Watanabe S, Sasaki Y, et al Norepinephrine, but not epinephrine, enhances platelet reactivity and coagulation after exercise in humans. Journal of applied physiology (Bethesda, Md: 1985). 1999; 86(1): 133– 8. Epub 1999/01/14. doi: 10.1152/jappl.1999.86.1.133. 9887123 · DOI
  37. [42]Badimon L, Martinez-Gonzalez J, Royo T, Lassila R, Badimon JJ. A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall—studies in a porcine model. Thrombosis and haemostasis. 1999; 82(6): 1736– 42. Epub 1999/12/29.. 10613663
  38. [43]Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. 1998; 12(3): 239– 44.. 9784902
  39. [44]Hubbard R, Lewis S, Smith C, Godfrey C, Smeeth L, Farrington P, et al Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control. 2005; 14(6): 416– 21. Epub 2005/12/02. doi: 10.1136/tc.2005.011387; PubMed Central PMCID: PMCPMC1748112. 16319366 PMC1748112 · DOI
  40. [45]Idris AM, Ibrahim SO, Vasstrand EN, Johannessen AC, Lillehaug JR, Magnusson B, et al The Swedish snus and the Sudanese toombak: are they different? Oral Oncol. 1998; 34(6): 558– 66.. 9930371
  41. [46]Turner JA, Sillett RW, McNicol MW. Effect of cigar smoking on carboxyhaemoglobin and plasma nicotine concentrations in primary pipe and cigar smokers and ex-cigarette smokers. Br Med J. 1977; 2(6099): 1387– 9.; PubMed Central PMCID: PMCPMC1632361. 589225 PMC1632361
  42. [47]Digard H, Errington G, Richter A, McAdam K. Patterns and behaviors of snus consumption in Sweden. Nicotine Tob Res. 2009; 11(10): 1175– 81. Epub 2009/08/19. doi: 10.1093/ntr/ntp118; PubMed Central PMCID: PMCPMC2746836. 19687306 PMC2746836 · DOI · Paper page
  43. [48]McAdam KG, Faizi A, Kimpton H, Porter A, Rodu B. Polycyclic aromatic hydrocarbons in US and Swedish smokeless tobacco products. Chemistry Central journal. 2013; 7(1): 151 Epub 2013/09/10. doi: 10.1186/1752-153X-7-151; PubMed Central PMCID: PMCPMC3874832. 24011230 PMC3874832 · DOI
  44. [49]Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008; 10(12): 1773– 82. Epub 2008/11/22. doi: 10.1080/14622200802443544; PubMed Central PMCID: PMCPMC2892835. 19023828 PMC2892835 · DOI
  45. [50]VanRooij JG, Bodelier-Bade MM, Jongeneelen FJ. Estimation of individual dermal and respiratory uptake of polycyclic aromatic hydrocarbons in 12 coke oven workers. Br J Ind Med. 1993; 50(7): 623– 32.; PubMed Central PMCID: PMCPMC1035498. 8343423 PMC1035498
  46. [51]Yang Q, Qiu X, Li R, Ma J, Li K, Li G. Polycyclic aromatic hydrocarbon (PAH) exposure and oxidative stress for a rural population from the North China Plain. Environ Sci Pollut Res Int. 2015; 22(3): 1760– 9. doi: 10.1007/s11356-014-3284-y. 25015715 · DOI
  47. [52]Martin JS, Beck DT, Gurovich AN, Braith RW. The acute effects of smokeless tobacco on central aortic blood pressure and wave reflection characteristics. Exp Biol Med (Maywood). 2010; 235(10): 1263– 8. Epub 2010/08/20. doi: 10.1258/ebm.2010.009376; PubMed Central PMCID: PMCPMC2971534. 20719817 PMC2971534 · DOI
  48. [53]Digard H, Proctor C, Kulasekaran A, Malmqvist U, Richter A. Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tob Res. 2013; 15(1): 255– 61. Epub 2012/05/16. doi: 10.1093/ntr/nts123; PubMed Central PMCID: PMCPMC3524070. 22585541 PMC3524070 · DOI · Paper page
  49. [54]Lee BL, Benowitz NL, Jacob P 3rd. Influence of tobacco abstinence on the disposition kinetics and effects of nicotine. Clinical pharmacology and therapeutics. 1987; 41(4): 474– 9. Epub 1987/04/01.. 3829584
  50. [55]Fattinger K, Verotta D, Benowitz NL. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. The Journal of pharmacology and experimental therapeutics. 1997; 281(3): 1238– 46. Epub 1997/06/01.. 9190859
  51. [56]Tanino Y, Shite J, Paredes OL, Shinke T, Ogasawara D, Sawada T, et al Whole body bioimpedance monitoring for outpatient chronic heart failure follow up. Circulation journal: official journal of the Japanese Circulation Society. 2009; 73(6): 1074– 9.. 19372625
  52. [57]Raaijmakers E, Faes TJ, Scholten RJ, Goovaerts HG, Heethaar RM. A meta-analysis of three decades of validating thoracic impedance cardiography. Critical care medicine. 1999; 27(6): 1203– 13. doi: 10.1097/00003246-199906000-00053. 10397230 · DOI
  53. [58]Sundstrom D, Waldenborg M, Emilsson K. Acute effects on the ventricular function in Swedish snuffers: an echocardiographic study. Clin Physiol Funct Imaging. 2012; 32(2): 106– 13. Epub 2012/02/03. doi: 10.1111/j.1475-097X.2011.01062.x. 22296630 · DOI
  54. [59]Alam M, Samad BA, Wardell J, Andersson E, Hoglund C, Nordlander R. Acute effects of smoking on diastolic function in healthy participants: studies by conventional doppler echocardiography and doppler tissue imaging. J Am Soc Echocardiogr. 2002; 15(10 Pt 2): 1232– 7.. 12411910
  55. [60]Janner JH, Godtfredsen NS, Ladelund S, Vestbo J, Prescott E. Aortic augmentation index: reference values in a large unselected population by means of the SphygmoCor device. Am J Hypertens. 2010; 23(2): 180– 5. doi: 10.1038/ajh.2009.234. 19959999 · DOI
  56. [61]Koskinen J, Magnussen CG, Viikari JS, Kahonen M, Laitinen T, Hutri-Kahonen N, et al Effect of age, gender and cardiovascular risk factors on carotid distensibility during 6-year follow-up. The cardiovascular risk in Young Finns study. Atherosclerosis. 2012; 224(2): 474– 9. Epub 2012/05/26. doi: 10.1016/j.atherosclerosis.2012.04.004. 22624989 · DOI
  57. [62]Hayward CS, Kelly RP. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol. 1997; 30(7): 1863– 71. Epub 1997/12/31.. 9385920
  58. [63]Gatzka CD, Kingwell BA, Cameron JD, Berry KL, Liang YL, Dewar EM, et al Gender differences in the timing of arterial wave reflection beyond differences in body height. J Hypertens. 2001; 19(12): 2197– 203.. 11725164
  59. [64]Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, et al Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004; 43(6): 1239– 45. Epub 2004/05/05. doi: 10.1161/01.HYP.0000128420.01881.aa. 15123572 · DOI
  60. [65]Russo C, Jin Z, Palmieri V, Homma S, Rundek T, Elkind MS, et al Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension. 2012; 60(2): 362– 8. doi: 10.1161/HYPERTENSIONAHA.112.191148; PubMed Central PMCID: PMCPMC3402954. 22753223 PMC3402954 · DOI
  61. [66]Mitchell GF, Gudnason V, Launer LJ, Aspelund T, Harris TB. Hemodynamics of increased pulse pressure in older women in the community-based Age, Gene/Environment Susceptibility-Reykjavik Study. Hypertension. 2008; 51(4): 1123– 8. doi: 10.1161/HYPERTENSIONAHA.107.108175. 18259005 PMC11106724 · DOI

Cited by

Sorted by citations

Authors
Antoniewicz, L., Novo, M., Bosson, J., & Lundbäck, M.
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2018-04-18
Volume
13
Issue
4
Pages
e0195493
ISSN
1932-6203
DOI
10.1371/journal.pone.0195493
PMC
PMC5905986
Cited by
8
References
2
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
  • Hjärt-Lungfonden
  • Svenska Läkaresällskapet
  • Stockholms Läns Landsting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review